ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barceló, A.
Right arrow Articles by Agustí, A. G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barceló, A.
Right arrow Articles by Agustí, A. G. N.
Eur Respir J 2006; 27:756-760
Copyright ©ERS Journals Ltd 2006

Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment

A. Barceló1, F. Barbé2, M. de la Peña1, M. Vila1, G. Pérez1, J. Piérola1, J. Durán3 and A. G. N. Agustí4

1 Serveis de Anàlisis Cliniques, 2 Pneumologia, Hospital Universitario Arnau de Vilanova Lleida, 3 Hospital Txagorritxu, Vitoria-Gasteiz, and 4 Hospital Universitari, Son Dureta, Institute Universitari de Ciencies de la Salut (IUNICS), Fundació Caubet-Cimera, Palma de Mallorca and Servicio de Neumología, Spain.

CORRESPONDENCE: A. Barceló, Servicio de Análisis Clínicos, Hospital, Universitari Son Dureta. C/ Andrea Doria 55, 07014 Palma de Mallorca, Spain. Fax: 34 971175228. E-mail: abarcelo{at}hsd.es

Keywords: Clinical trial, continuous positive airway pressure, oxidative stress

Received: June 10, 2005
Accepted November 25, 2005

The episodes of hypoxia/re-oxygenation associated with the respiratory disturbances observed in patients with obstructive sleep apnoea syndrome (OSAS) may induce the generation of oxygen free radicals. Indeed, several studies suggest that OSAS is associated with oxidative stress. The present study tested the hypothesis that patients with OSAS have an alteration in antioxidant defences.

The plasma levels of total antioxidant status (TAS), glutathione peroxidase (GPX), {gamma}-glutamyltransferase (GGT), vitamins A, E, B12 and folate, and homocysteine were determined in 47 patients with OSAS and 37 healthy subjects. Of these, 27 patients who used continuous positive airway pressure (CPAP) for >4 h·night–1 were re-examined 12 months later.

Patients with OSAS had lower TAS (1.4±0.16 versus 1.50±0.10 mmol·L–1), vitamin A (64±19 versus 74±17 µg·dL–1) and vitamin E levels (1,525±499 versus 1,774±503 µg·dL–1), and increased values of GGT (42±22 versus 32±16 U·L–1) than controls. There was no difference between groups in GPX, homocysteine, vitamin B12 and folate plasma levels. CPAP treatment normalised the levels of TAS (1.50±0.13 mmol·L–1) and the activity of GGT (30±14 U·L–1) without any influence on vitamins levels.

In conclusion, the results indicate that patients with obstructive sleep apnoea syndrome have a decreased antioxidant capacity that is partially reversed by continuous positive airway pressure treatment.




This article has been cited by other articles:


Home page
 ThoraxHome page
M D Cross, N L Mills, M Al-Abri, R Riha, M Vennelle, T W Mackay, D E Newby, and N J Douglas
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial
Thorax, July 1, 2008; 63(7): 578 - 583.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Faure, R. Tamisier, J-P. Baguet, A. Favier, S. Halimi, P. Levy, and J-L. Pepin
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome
Eur. Respir. J., May 1, 2008; 31(5): 1046 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Proceedings of the ATS, February 15, 2008; 5(2): 161 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Gozal and L. Kheirandish-Gozal
Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 369 - 375.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
A. I. Sergueeva, G. Y. Miasnikova, D. J. Okhotin, A. A. Levina, Z. Debebe, T. Ammosova, X. Niu, E. A. Romanova, S. Nekhai, P. M. DiBello, et al.
Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation
Haematologica, February 1, 2008; 93(2): 279 - 282.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Kheirandish-Gozal, O. Sans Capdevila, E. Kheirandish, and D. Gozal
Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep Apnea
Chest, January 1, 2008; 133(1): 92 - 99.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. H. Le Jemtel and S. Jelic
Seek and Treat Obstructive Sleep Apnea in Heart Failure
J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1632 - 1633.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
C. L. Phillips and R. R. Grunstein
Obstructive sleep apnoea: time for a radical change?
Eur. Respir. J., April 1, 2006; 27(4): 671 - 673.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.